Learning Objectives:

1. Review clinical experience with propranolol in infantile hemangiomas and anecdotal reports of effect on cavernous angiomas.

2. Present novel mechanistic discoveries in Zebrafish and mouse models.

3. Relevance regarding mechanisms of action, dose-effect, and design of clinical trials.

Session date: 
02/10/2021 - 8:30am to 9:30am CST
University of Chicago Medical Center
5841 S. Maryland Avenue
Virtual Meeting via Zoom
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Issam A. Awad, MD, MSc, FACS, MA (hon)